Findings

What do systematic reviews say?

1 questions · 1 findings · 1 reviews · Urology

No studies found 0 · 0%GRADE not reported 0 · 0%Very low 0 · 0%Low 1 · 100%Moderate 0 · 0%High 0 · 0%

Time to progression · patients with non‐muscle invasive bladder cancer

Blue light may leads to lower time to disease progression (absolute event rates based on 12 months compared with white light (low certainty).

1 finding from 1 review

Blue versus white light for transurethral resection of non‐muscle invasive bladder cancer 2021 · Cochrane Headline outcomes only
HR 0.65 [0.5, 0.84]
9 studies · 2200 participants
Low